scholarly journals Association between attendance at an American diabetes camp and improvements in glycaemic control and treatment satisfaction

2021 ◽  
Author(s):  
Amy Darukhanavala ◽  
Sarah Puhr ◽  
Kyle Dinunno ◽  
David Alfego ◽  
John Welsh ◽  
...  
Keyword(s):  
Glycaemic Control ◽  
Treatment Satisfaction ◽  
Diabetes Camp

Treatment satisfaction correlated with glycaemic control and burden of diabetes in Swedish adolescents with type 1 diabetes

2019 ◽  
Vol 109 (3) ◽  
pp. 573-580
Author(s):  
Josephine Haas ◽  
Martina Persson ◽  
Eva Hagström Toft ◽  
Björn Rathsman ◽  
Anna‐Lena Brorsson ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycaemic Control ◽  
Treatment Satisfaction

823-P: Diabetes Camp Experience Associated with Improved Glycemia and Treatment Satisfaction

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 823-P
Author(s):  
AMY DARUKHANAVALA ◽  
KYLE V. DINUNNO ◽  
SARAH PUHR ◽  
JOHN B. WELSH ◽  
LYNN BUTLER ◽  
...  
Keyword(s):  
Treatment Satisfaction ◽  
Diabetes Camp

The Real-Life Effectiveness and Care Patterns of Type 2 Diabetes Management in Greece

2017 ◽  
Vol 126 (01) ◽  
pp. 53-60 ◽  
Author(s):  
Emmanuel Pagkalos ◽  
Anastasia Thanopoulou ◽  
Christos Sampanis ◽  
Stavros Bousboulas ◽  
Andreas Melidonis ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycaemic Control ◽  
Treatment Adherence ◽  
Treatment Satisfaction ◽  
Diabetes Management ◽  
Severe Hypoglycaemia ◽  
Univariate Analysis ◽  
Real Life ◽  
Control Treatment

Abstract Aim To investigate the prevalence of hypoglycaemia during sulfonylurea (SU) treatment of type 2 diabetes mellitus (T2DM) in Greece and its influence on glycaemic control, treatment adherence and quality of life (QoL). Patients and methods This was a retrospective cross-sectional study. We included 383 T2DM patients ≥30 years old on treatment with SU in monotherapy or in combination with metformin for at least 6 months. Patients were requested to fill in retrospective questionnaires on hypoglycaemia experience, adherence, weight gain and lifestyle/behavioural factors along with QoL (EQ-5D-3L), treatment satisfaction (TSQM), and fear of hypoglycaemia (HFS-II Worry scale). Results HbA1c<7% was found in 161 (42.0%) patients. In total, 165 (43.1%) patients reported hypoglycaemic symptoms during the previous 6 months: 41.6% (67/161) of those with HbA1c <7% and 44.1% (98/222) of those with HbA1c ≥7%. Glycaemic control was achieved by 43.1% (94/218) of patients without hypoglycaemia and 50.0% (41/82), 36.8% (25/68) and 6.7% (1/15) of patients with mild, moderate or severe hypoglycaemia, respectively (p=0.013). In multivariate analysis, both occurrence (none vs. mild/moderate/severe) and severity (none vs. mild vs. moderate vs. severe) of hypoglycaemia were significantly associated with impaired global treatment satisfaction (p=0.002 and p<0.0001 respectively) and HFS-II Worry scale scores (both p<0.0001), while lower QoL (EQ-5D (UK) Index) was related to hypoglycaemia severity (p=0.024) only. Finally, treatment adherence was associated with increased (none/mild vs. moderate/severe) hypoglycaemia severity in univariate analysis (p=0.019). Conclusion A high prevalence of patient treated with SU reported hypoglycaemia in Greek healthcare settings with negative effects on treatment satisfaction, patient worry and adherence. Severity of hypoglycaemic symptoms was associated with reduced glycaemic control.

Sign in / Sign up

Export Citation Format

Share Document